Announced record preliminary financial results for the second quarter of 2022. Record revenue estimated to be $36 million (95 million New Israeli Shekels), more than double the revenues of the second quarter of 2021 and representing sequential growth of over 9%.InterCure Ltd. shares T.INCR.U are trading unchanged at $6.05.
Stocks in play: InterCure Ltd.
Baystreet.ca - Baystreet - Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here